Sp635

IMMUNISATION AND SUSCEPTIBILITY TO INFECTION IN PATIENTS WITH IBD

Date
May 7, 2023
Explore related products in the following collection:

Society: AGA

The Cochrane Gut group supports the production of high quality and methodologically rigorous reviews for a portfolio that includes upper GI, IBD and functional bowel disease topics in adults and children. In this session, three themes will be discussed that are very relevant to IBD care in a world recovering from and living with COVID. We will discuss immunization and susceptibility to infection in IBD patients. We will consider remote telehealth and patient education to support distance and patient directed care, Finally, we will consider Long-COVID in IBD. Each presentation will consider evidence synthesis in the form of Cochrane and none Cochrane reviews, as well as critically appraising the literature in a manner that supports transparency and clinical utility of findings. After each presentation, our panel of speakers and the moderators will discuss the relevance of the findings in relation to current practice and guidance and explore where gaps exist.

Presenter


Tracks

Related Products

Thumbnail for PANEL DISCUSSION: IMMUNISATION AND SUSCEPTIBILITY TO INFECTION IN PATIENTS WITH IBD
PANEL DISCUSSION: IMMUNISATION AND SUSCEPTIBILITY TO INFECTION IN PATIENTS WITH IBD
The Cochrane Gut group supports the production of high quality and methodologically rigorous reviews for a portfolio that includes upper GI, IBD and functional bowel disease topics in adults and children…
Thumbnail for HABITUAL MEAT INTAKE IS ASSOCIATED WITH INCREASED RISK OF DISEASE FLARE IN ULCERATIVE COLITIS: INITIAL RESULTS FROM THE PREDICCT STUDY
HABITUAL MEAT INTAKE IS ASSOCIATED WITH INCREASED RISK OF DISEASE FLARE IN ULCERATIVE COLITIS: INITIAL RESULTS FROM THE PREDICCT STUDY
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Thumbnail for PANEL DISCUSSION: LONG-TERM OUTCOMES AND COMPLICATIONS OF COVID IN IBD PATIENTS
PANEL DISCUSSION: LONG-TERM OUTCOMES AND COMPLICATIONS OF COVID IN IBD PATIENTS
The Cochrane Gut group supports the production of high quality and methodologically rigorous reviews for a portfolio that includes upper GI, IBD and functional bowel disease topics in adults and children…
Thumbnail for INTRODUCTION
INTRODUCTION
SOCIETY: AGA